background
precis
etiolog
diagnosi
pediatr
communityacquir
pneumonia
cap
remain
challeng
method
conduct
retrospect
studi
cap
etiolog
group
pediatr
patient
underw
flexibl
bronchoscopi
fob
bronchoalveolar
lavag
bal
children
acut
nonrespons
cap
nrcap
n
recurr
cap
reccap
n
procedur
measur
taken
limit
contamin
risk
quantit
bacteri
cultur
bal
fluid
signific
cutoff
point
colonyform
unitsml
use
blood
cultur
result
serolog
test
result
nasopharyng
secret
find
pleural
fluid
cultur
result
also
assess
avail
result
infecti
agent
detect
case
infect
aerob
bacteria
isol
haemophilu
influenza
moraxella
catarrhali
streptococcu
pneumonia
respect
h
influenza
strain
nontyp
nthi
h
influenza
detect
nrcap
case
reccap
case
wherea
mycoplasma
pneumonia
predomin
pathogen
nrcap
group
account
case
reccap
group
virus
found
case
respiratori
syncyti
viru
parainfluenzavirus
influenzavirus
detect
frequent
mix
infect
found
nrcap
case
reccap
case
conclus
varieti
microorgan
isol
frequent
mix
infect
nthi
one
major
pathogen
found
especi
associ
recurr
cap
possibl
improv
detect
fob
bal
procedur
suggest
burden
pediatr
cap
could
reduc
address
nthi
major
caus
pathogen
direct
sampl
lung
lower
airway
achiev
invas
method
transthorac
needl
aspir
tna
punctur
pleural
effus
adult
sputum
sampl
consid
valuabl
noninvas
altern
bacteri
detect
often
feasibl
obtain
sputum
sampl
children
therefor
pediatr
studi
base
sampl
obtain
upper
respiratori
tract
urt
blood
sampl
howev
urt
frequent
colon
bacteri
pathogen
make
difficult
discrimin
commens
organ
acut
pathogen
moreov
although
blood
normal
steril
blood
cultur
highli
specif
sensit
blood
cultur
childhood
cap
low
serolog
test
detect
virus
atyp
microorgan
limit
use
clinic
practic
need
convalescentphas
serum
sampl
flexibl
bronchoscopi
fob
bronchoalveolar
lavag
bal
option
noninvas
sampl
lower
respiratori
tract
lrt
imposs
obtain
select
patient
nonrespons
antibiot
treatment
bal
fluid
advantag
suitabl
multipl
detect
method
includ
microscopi
aerob
cultur
viral
cultur
polymeras
chain
reaction
pcr
protect
brush
pass
pediatr
flexibl
bronchoscop
risk
oropharyng
contamin
reduc
consider
care
techniqu
interpret
bal
result
reliabl
use
quantit
bacteri
cultur
reliabl
fob
plu
bal
use
precaut
demonstr
author
report
specif
potenti
pathogen
relat
actual
pneumonia
moreov
fob
plu
bal
proven
safe
even
critic
ill
children
retrospect
studi
assess
etiolog
cap
group
pediatr
patient
underw
fob
plu
bal
children
acut
nonrespons
cap
children
recurr
cap
among
children
cap
featur
account
signific
proport
physician
emerg
depart
visit
hospit
antibiot
prescrib
commun
addit
bal
fluid
cultur
blood
cultur
serolog
test
cultur
pcr
result
nasopharyng
aspir
nasopharyng
secret
npa
pleural
fluid
cultur
assess
avail
retrospect
analysi
pediatr
patient
underw
fob
plu
bal
januari
decemb
studi
approv
ethic
committe
universitair
ziekenhui
brussel
uz
brussel
belgium
patient
select
analysi
acut
nonrespons
communityacquir
broncho
pneumonia
nrcap
group
recurr
communityacquir
broncho
pneumonia
reccap
group
nrcap
case
patient
defin
accord
current
pediatr
cap
guidelin
patient
persist
fever
persist
elev
infect
paramet
peripher
blood
associ
case
worsen
consolid
visibl
chest
radiograph
least
h
antibiot
treatment
reccap
group
episod
cap
histori
least
cap
episod
exclus
criteria
includ
presenc
sever
chronic
condit
cystic
fibrosi
primari
ciliari
diseas
immun
defici
bronchopulmonari
dysplasia
cardiopathi
neuromuscular
diseas
asplenia
tuberculosi
nosocomi
respiratori
tract
infect
retrospect
analys
conduct
demograph
data
antibiot
use
fob
plu
bal
result
broad
microbiolog
investig
fob
bal
perform
accord
european
respiratori
societi
recommend
pediatr
flexibl
fiberopt
bronchoscop
olympu
insert
oral
avoid
nasal
contamin
aliquot
salin
solut
instil
reaspir
diseas
lobar
segment
bronchu
maximum
volum
mlkg
bodi
weight
first
bronchial
lavag
fraction
discard
subject
sedat
intraven
midazolam
atropinesulph
tramadol
hydrochlorid
transcutan
monitor
oxygen
satur
heart
rate
receiv
supplementari
oxygen
need
procedur
blood
cultur
serolog
test
perform
accord
routin
procedur
cap
diagnos
start
antibiot
treatment
npa
perform
routin
children
year
age
cap
use
flexibl
steril
cathet
vagin
cathet
medinorm
introduc
nostril
nasopharynx
level
salin
solut
ml
instil
immedi
reaspir
pleural
fluid
obtain
patient
signific
amount
pleural
fluid
safe
punctur
use
routin
disinfect
punctur
method
sampl
process
use
standard
techniqu
interpret
list
tabl
haemophilu
influenza
biotyp
capsular
type
use
pcr
agglutin
techniqu
perform
centr
hospitali
universitair
st
pierr
brussel
nontyp
h
influenza
nthi
strain
distinguish
nonhemolyt
haemophilu
haemolyticu
blactamas
activ
assess
use
nitrocephinbas
test
antibiot
suscept
determin
etest
techniqu
serotyp
antibiot
suscept
test
streptococcu
pneumonia
perform
describ
elsewher
viral
cultur
inhous
multiplex
pcr
mpcr
use
bal
fluid
npa
detect
respiratori
virus
atyp
microorgan
mycoplasma
pneumonia
chlamydophila
pneumonia
serolog
test
perform
complement
fixat
techniqu
v
test
yate
correct
one
subject
figur
fisher
exact
test
use
compar
posit
rate
group
statist
signific
differ
defin
probabl
occurr
children
fob
plu
bal
nrcap
reccapmet
inclus
criteria
median
age
sex
ratio
group
similar
tabl
patient
nrcap
receiv
antibiot
treatment
within
h
fob
plu
bal
wherea
patient
reccap
treat
tabl
pathogen
detect
approxim
threequart
children
group
tabl
exclus
bacteri
pathogen
found
nrcap
group
reccap
group
mix
infect
found
respect
bacteri
pathogen
except
pneumonia
isol
bal
specimen
wherea
blood
cultur
pleural
fluid
cultur
posit
patient
posit
blood
cultur
pneumonia
isol
blood
cultur
wherea
h
influenza
catharrali
isol
bal
specimen
patient
patient
staphylococcu
aureu
isol
pleural
fluid
cultur
wherea
bal
yield
organ
combin
enterobact
aerogen
latter
case
pneumonia
isol
pleural
fluid
specimen
bal
blood
cultur
remain
neg
overal
aerob
bacteria
isol
patient
infect
aerob
bacteria
isol
h
influenza
bacteri
pathogen
found
significantli
often
patient
reccap
patient
nrcap
tabl
remain
case
h
influenza
found
anoth
bacteri
pathogen
moraxella
catarrhali
case
pneumonia
case
aureu
case
h
influenza
found
mix
bacterialvir
infect
mix
bacterialatyp
infect
mix
infect
mycoplasma
speci
respiratori
viru
tabl
h
influenza
isol
nthi
lost
type
three
isol
initi
misidentifi
agglutin
techniqu
encapsul
strain
type
e
type
b
howev
pcr
result
neg
case
result
definit
identif
nthi
major
h
influenza
isol
blactamas
neg
includ
isol
nrcap
case
isol
reccap
case
two
blactamaseneg
isol
intermedi
suscept
ampicillin
minimum
inhibitori
concentr
mic
mgl
blactamaseneg
fulli
ampicillinresist
strain
detect
h
influenza
catarrhali
pneumonia
next
common
bacteri
pathogen
account
case
respect
aerob
bacteria
isol
catarrhali
isol
nrcap
case
reccap
case
wherea
pneumonia
isol
nrcap
case
reccap
case
tabl
although
pneumonia
isol
case
varieti
pneumococc
serogroupsserotyp
sgt
found
predomin
sgt
isol
case
respect
pneumonia
isol
fulli
suscept
parenter
administr
penicillin
mic
lgml
wherea
isol
intermedi
suscept
oral
administr
penicillin
mic
lgml
catarrhali
pneumonia
mostli
found
anoth
bacteri
pathogen
case
respect
atyp
microorgan
alon
detect
significantli
often
patient
nrcap
patient
reccap
tabl
pneumonia
detect
sampl
patient
nrcap
test
sampl
patient
reccap
test
c
pneumonia
detect
reccap
case
tabl
virus
found
case
overal
exclus
viral
infect
report
nrcap
case
reccap
case
tabl
overal
respiratori
syncyti
viru
rsv
parainfluenzavirus
influenzavirus
adenoviru
human
metapneumoviru
detect
frequent
tabl
viral
coinfect
found
nrcap
reccap
case
assess
otherwis
healthi
children
either
nrcap
reccap
determin
etiolog
infect
heterogen
group
patient
includ
reflect
pediatr
cap
case
often
requir
hospit
develop
countri
infecti
agent
detect
case
compar
detect
case
previou
studi
pediatr
cap
howev
studi
involv
urt
sampl
thu
limit
specif
detect
bacteri
pathogen
studi
involv
sampl
lrt
lung
aspir
among
aerob
bacteria
isol
approxim
half
infect
found
predomin
nthi
group
children
approxim
threequart
h
influenza
nthi
knowledg
first
report
find
sinc
shann
et
al
weinberg
et
al
sinc
studi
involv
children
cap
lrt
infect
use
serolog
test
tna
suggest
possibl
role
nthi
pediatr
pneumonia
fail
defin
signific
pathogen
exampl
recent
studi
involv
children
cap
case
attribut
pneumonia
case
h
influenza
infect
found
use
tna
howev
studi
includ
small
number
patient
investig
lobar
cap
also
possibl
nthi
infect
miss
previou
studi
pediatr
cap
methodolog
appropri
nthi
detect
nthi
easili
invad
bloodstream
pleura
misclassif
nthi
strain
hib
strain
use
slide
agglutin
techniqu
report
also
mani
tna
studi
cultur
media
use
appropri
detect
h
influenza
h
influenza
found
strain
serotyp
reliabl
find
nthi
frequent
involv
pathogen
childhood
cap
support
steril
lrt
healthi
subject
find
children
unilater
cap
bal
cultur
contralater
side
neg
result
well
establish
pathogen
nthi
anoth
normal
steril
site
middl
ear
nthi
associ
persist
nonrespons
acut
otiti
media
aom
possibl
attribut
choic
treatment
amoxicillin
use
firstlin
treatment
lead
select
blactamaseposit
h
influenza
case
studi
nthi
isol
blactamas
neg
aom
nthi
clear
associ
recurr
month
complet
antibiot
therapi
incid
third
subsequ
episod
nthi
infect
contribut
complic
aom
clinic
indistinguish
aom
caus
pneumonia
therefor
possibl
chlamydophila
pneumonia
test
test
ns
note
nrcap
nonrespond
communityacquir
pneumonia
reccap
recurr
communityacquir
pneumonia
coinfect
case
least
infect
agent
microbiolog
group
isol
ns
signific
n
virus
aom
nthi
innoc
bystand
lrt
inde
increasingli
recogn
nthi
capabl
caus
invas
diseas
particularli
neonat
sepsi
also
caus
cap
bacteremia
lesser
extent
mening
moreov
confid
risk
contamin
bal
sampl
limit
consider
variou
technic
measur
taken
avoid
contamin
urt
secret
signific
cutoff
valu
use
bacteri
bal
cultur
although
signific
cutoff
colonyform
unit
cfu
ml
shown
reliabl
adult
chosen
use
higher
cutoff
valu
cfuml
colon
urt
common
children
find
haemophilu
strain
detect
studi
nonhemolyt
h
haemolyticu
wherea
previou
studi
show
preval
nonhemolyt
h
haemolyticu
throat
swab
sampl
obtain
healthi
children
adult
also
support
reliabl
result
typic
bacteri
pathogen
pneumonia
catarrhali
pneumonia
detect
case
respect
aerob
bacteria
isol
bacteri
coinfect
report
sever
earlier
studi
includ
studi
use
tna
coinfect
due
pneumonia
h
influenza
although
coinfect
due
h
influenza
catarrhali
record
studi
also
report
although
role
isol
pathogen
defin
previou
find
coinfect
recent
insight
interspeci
quorum
signal
suggest
individu
role
pathogen
andor
possibl
interact
belgium
univers
childhood
vaccin
h
influenza
type
b
hib
introduc
might
explain
absenc
case
infect
due
hib
studi
howev
univers
childhood
pneumococc
vaccin
use
start
unlik
may
influenc
result
proport
case
identifi
etiolog
compar
group
bacteri
etiolog
found
often
reccap
case
nrcap
case
probabl
approxim
quarter
patient
reccap
receiv
antibiot
fob
plu
bal
antibioticpretr
patient
diagnost
yield
might
increas
use
bacteri
serolog
test
quantit
pcr
rel
low
detect
rate
pneumonia
c
pneumonia
may
relat
young
age
patient
atyp
infect
common
children
year
age
pneumonia
predomin
pathogen
nrcap
group
reccap
group
patient
nrcap
treat
penicillin
aminopenicillin
firstlin
antibiot
treatment
cap
predomin
pneumonia
give
possibl
reason
nonrespons
virus
found
case
rsv
parainfluenzavirus
influenzavirus
detect
frequent
incid
rel
low
compar
find
studi
may
due
omiss
rhinoviru
pcr
assay
viru
detect
slightli
frequent
nrcap
group
virus
sole
pathogen
twice
often
nrcap
group
reccap
group
possibl
provid
anoth
explan
nonrespons
initi
antibiot
therapi
viral
coinfect
found
case
overal
rare
report
studi
cap
although
one
studi
report
incid
cap
case
viral
cap
case
mix
infect
found
case
compar
previou
find
find
compat
current
guidelin
recommend
antibiot
treatment
cap
case
establish
viral
atyp
etiolog
rule
concomit
bacteri
infect
predomin
nthi
reccap
case
studi
suggest
use
aminopenicillin
without
blactamas
inhibitor
initi
treatment
recurr
case
case
nonrespons
addit
macrolid
initi
treatment
regimen
support
rel
high
incid
pneumonia
infect
nrcap
case
conclus
previou
studi
found
varieti
microorgan
involv
pediatr
nonrespons
recurr
cap
frequent
mix
infect
contrast
report
found
nthi
major
bacteri
pathogen
possibl
improv
detect
fob
plu
bal
find
might
explain
case
nonrespons
antibiot
treatment
recurr
pediatr
cap
similar
observ
aom
frequent
associ
nthi
infect
addit
research
need
elucid
pathogen
mechan
nthi
pediatr
cap
howev
find
suggest
burden
pediatr
cap
could
reduc
address
nthi
major
caus
pathogen
treatment
prevent
strategi
